Cover Image

Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial: correction

Saved in:
Bibliographic Details
Main Authors: Flygt, Hjalmar (Author) , Söderlund, Stina (Author) , Richter, Johan (Author) , Saußele, Susanne (Author) , Koskenvesa, Perttu (Author) , Stenke, Leif (Author) , Mustjoki, Satu (Author) , Dimitrijevic, Andreja (Author) , Stentoft, Jesper (Author) , Majeed, Waleed (Author) , Roy, Lydia (Author) , Wolf, Dominik (Author) , Dreimane, Arta (Author) , Gjertsen, Bjørn Tore (Author) , Gedde-Dahl, Tobias (Author) , Ahlstrand, Erik (Author) , Markevärn, Berit (Author) , Hjorth-Hansen, Henrik (Author) , Janssen, Jeroen (Author) , Olsson-Strömberg, Ulla (Author)
Format: Article (Journal) Editorial
Language:English
Published: April 2024
In: Leukemia
Year: 2024, Volume: 38, Issue: 4, Pages: 925-925
ISSN:1476-5551
DOI:10.1038/s41375-024-02184-z
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41375-024-02184-z
Verlag, kostenfrei, Volltext: http://www.nature.com/articles/s41375-024-02184-z
Get full text
Author Notes:Hjalmar Flygt, Stina Söderlund, Johan Richter, Susanne Saussele, Perttu Koskenvesa, Leif Stenke, Satu Mustjoki, Andreja Dimitrijevic, Jesper Stentoft, Waleed Majeed, Lydia Roy, Dominik Wolf, Arta Dreimane, Bjørn Tore Gjertsen, Tobias Gedde-Dahl, Erik Ahlstrand, Berit Markevärn, Henrik Hjorth-Hansen, Jeroen Janssen and Ulla Olsson-Strömberg

MARC

LEADER 00000caa a2200000 c 4500
001 1908288280
003 DE-627
005 20241205220058.0
007 cr uuu---uuuuu
008 241112s2024 xx |||||o 00| ||eng c
024 7 |a 10.1038/s41375-024-02184-z  |2 doi 
035 |a (DE-627)1908288280 
035 |a (DE-599)KXP1908288280 
035 |a (OCoLC)1475647327 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Flygt, Hjalmar  |e VerfasserIn  |0 (DE-588)1348028327  |0 (DE-627)1908287527  |4 aut 
245 1 0 |a Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial  |b correction  |c Hjalmar Flygt, Stina Söderlund, Johan Richter, Susanne Saussele, Perttu Koskenvesa, Leif Stenke, Satu Mustjoki, Andreja Dimitrijevic, Jesper Stentoft, Waleed Majeed, Lydia Roy, Dominik Wolf, Arta Dreimane, Bjørn Tore Gjertsen, Tobias Gedde-Dahl, Erik Ahlstrand, Berit Markevärn, Henrik Hjorth-Hansen, Jeroen Janssen and Ulla Olsson-Strömberg 
264 1 |c April 2024 
300 |a 1 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlicht: 28. Februar 2024 
500 |a Gesehen am 12.11.2024 
650 4 |a Myeloproliferative disease 
650 4 |a Targeted therapies 
700 1 |a Söderlund, Stina  |e VerfasserIn  |4 aut 
700 1 |a Richter, Johan  |e VerfasserIn  |4 aut 
700 1 |a Saußele, Susanne  |d 1968-  |e VerfasserIn  |0 (DE-588)115839860  |0 (DE-627)69162786X  |0 (DE-576)29010694X  |4 aut 
700 1 |a Koskenvesa, Perttu  |e VerfasserIn  |4 aut 
700 1 |a Stenke, Leif  |e VerfasserIn  |4 aut 
700 1 |a Mustjoki, Satu  |e VerfasserIn  |4 aut 
700 1 |a Dimitrijevic, Andreja  |e VerfasserIn  |4 aut 
700 1 |a Stentoft, Jesper  |e VerfasserIn  |4 aut 
700 1 |a Majeed, Waleed  |e VerfasserIn  |4 aut 
700 1 |a Roy, Lydia  |e VerfasserIn  |4 aut 
700 1 |a Wolf, Dominik  |e VerfasserIn  |4 aut 
700 1 |a Dreimane, Arta  |e VerfasserIn  |4 aut 
700 1 |a Gjertsen, Bjørn Tore  |e VerfasserIn  |4 aut 
700 1 |a Gedde-Dahl, Tobias  |e VerfasserIn  |4 aut 
700 1 |a Ahlstrand, Erik  |e VerfasserIn  |4 aut 
700 1 |a Markevärn, Berit  |e VerfasserIn  |4 aut 
700 1 |a Hjorth-Hansen, Henrik  |e VerfasserIn  |4 aut 
700 1 |a Janssen, Jeroen  |e VerfasserIn  |4 aut 
700 1 |a Olsson-Strömberg, Ulla  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Leukemia  |d London : Springer Nature, 1997  |g 38(2024), 4 vom: Apr., Seite 925-925  |h Online-Ressource  |w (DE-627)32046699X  |w (DE-600)2008023-2  |w (DE-576)094139733  |x 1476-5551  |7 nnas  |a Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial correction 
773 1 8 |g volume:38  |g year:2024  |g number:4  |g month:04  |g pages:925-925  |g extent:1  |a Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial correction 
787 0 8 |i Errata zu  |a Flygt, Hjalmar  |t Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial  |d 2024  |w (DE-627)190828711X 
856 4 0 |u https://doi.org/10.1038/s41375-024-02184-z  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://www.nature.com/articles/s41375-024-02184-z  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20241112 
993 |a Editorial 
994 |a 2024 
998 |g 115839860  |a Saußele, Susanne  |m 115839860:Saußele, Susanne  |d 60000  |d 61200  |d 60000  |e 60000PS115839860  |e 61200PS115839860  |e 60000PS115839860  |k 0/60000/  |k 1/60000/61200/  |k 0/60000/  |p 4 
999 |a KXP-PPN1908288280  |e 4613333008 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Online veröffentlicht: 28. Februar 2024","Gesehen am 12.11.2024"],"recId":"1908288280","language":["eng"],"person":[{"given":"Hjalmar","family":"Flygt","role":"aut","roleDisplay":"VerfasserIn","display":"Flygt, Hjalmar"},{"given":"Stina","family":"Söderlund","role":"aut","display":"Söderlund, Stina","roleDisplay":"VerfasserIn"},{"family":"Richter","given":"Johan","display":"Richter, Johan","roleDisplay":"VerfasserIn","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Saußele, Susanne","role":"aut","family":"Saußele","given":"Susanne"},{"role":"aut","display":"Koskenvesa, Perttu","roleDisplay":"VerfasserIn","given":"Perttu","family":"Koskenvesa"},{"display":"Stenke, Leif","roleDisplay":"VerfasserIn","role":"aut","family":"Stenke","given":"Leif"},{"family":"Mustjoki","given":"Satu","display":"Mustjoki, Satu","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Dimitrijevic","given":"Andreja","display":"Dimitrijevic, Andreja","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Jesper","family":"Stentoft","role":"aut","display":"Stentoft, Jesper","roleDisplay":"VerfasserIn"},{"given":"Waleed","family":"Majeed","role":"aut","display":"Majeed, Waleed","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Roy, Lydia","given":"Lydia","family":"Roy"},{"roleDisplay":"VerfasserIn","display":"Wolf, Dominik","role":"aut","family":"Wolf","given":"Dominik"},{"role":"aut","display":"Dreimane, Arta","roleDisplay":"VerfasserIn","given":"Arta","family":"Dreimane"},{"role":"aut","display":"Gjertsen, Bjørn Tore","roleDisplay":"VerfasserIn","given":"Bjørn Tore","family":"Gjertsen"},{"family":"Gedde-Dahl","given":"Tobias","roleDisplay":"VerfasserIn","display":"Gedde-Dahl, Tobias","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Ahlstrand, Erik","given":"Erik","family":"Ahlstrand"},{"given":"Berit","family":"Markevärn","role":"aut","roleDisplay":"VerfasserIn","display":"Markevärn, Berit"},{"roleDisplay":"VerfasserIn","display":"Hjorth-Hansen, Henrik","role":"aut","family":"Hjorth-Hansen","given":"Henrik"},{"display":"Janssen, Jeroen","roleDisplay":"VerfasserIn","role":"aut","family":"Janssen","given":"Jeroen"},{"family":"Olsson-Strömberg","given":"Ulla","display":"Olsson-Strömberg, Ulla","roleDisplay":"VerfasserIn","role":"aut"}],"title":[{"title":"Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial","subtitle":"correction","title_sort":"Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial"}],"physDesc":[{"extent":"1 S."}],"relHost":[{"id":{"issn":["1476-5551"],"zdb":["2008023-2"],"eki":["32046699X"]},"origin":[{"dateIssuedDisp":"1997-","dateIssuedKey":"1997","publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group","publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Leukemia","subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal","title_sort":"Leukemia"}],"language":["eng"],"recId":"32046699X","type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 15.03.04"],"disp":"Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial correctionLeukemia","part":{"extent":"1","text":"38(2024), 4 vom: Apr., Seite 925-925","volume":"38","pages":"925-925","issue":"4","year":"2024"},"pubHistory":["Nachgewiesen 11.1997 -"]}],"name":{"displayForm":["Hjalmar Flygt, Stina Söderlund, Johan Richter, Susanne Saussele, Perttu Koskenvesa, Leif Stenke, Satu Mustjoki, Andreja Dimitrijevic, Jesper Stentoft, Waleed Majeed, Lydia Roy, Dominik Wolf, Arta Dreimane, Bjørn Tore Gjertsen, Tobias Gedde-Dahl, Erik Ahlstrand, Berit Markevärn, Henrik Hjorth-Hansen, Jeroen Janssen and Ulla Olsson-Strömberg"]},"origin":[{"dateIssuedDisp":"April 2024","dateIssuedKey":"2024"}],"id":{"eki":["1908288280"],"doi":["10.1038/s41375-024-02184-z"]}} 
SRT |a FLYGTHJALMCORRECTION2024 

Similar Items